Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma

NCT05577000 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Refractory Multiple Myeloma
Relapsed Multiple Myeloma

Interventions

BIOLOGICAL: Manufactured Anti-BCMA CAR-T cells
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Thomas Martin, MD

Collaborators

[object Object]
[object Object]
[object Object]